We are united in purpose.

The history of our success lies in our ability to apply it to the future. We are pioneering science in the field of virus-specific T cell (VST) therapies and embrace a shared commitment to our mission to prevent and defeat life-threatening viral diseases.

We champion truth and challenge the status quo in pursuit of continuous improvement in the fight against viral diseases. Our innovative spirit lives beyond the lab, in a world where everyone has access to a healthy immune system.

Immunity for All.

Our Leadership
‍

Diana M. Brainard, MD

Chief Executive Officer, AlloVir

Diana Brainard, MD, has more than 20 years of experience in academic medicine and the biopharmaceutical industry, has authored more than 200 publications, and brings a passion for advancing therapies for life-threatening diseases.

President and Chief Financial Officer

Vikas Sinha brings more than 25 years of experience in executive finance roles within the biopharmaceutical industry.

Chief Scientific Officer

For more than 20 years, Ann Leen, PhD, has led innovative discovery and translational research focused on developing novel T cell-based therapies.

Senior Vice President, Technical Operations

Dana Alexander brings more than 20 years of experience in biopharmaceutical operations for start-up, late clinical-stage, and commercial biologic products.

Senior Vice President, Corporate Affairs and Investor Relations

Sonia Choi brings more than two decades of experience leading global, regional, and in-market communications within the biopharmaceutical industry.

General Counsel

Edward Miller has more than 25 years of diverse legal and business experience in the biotechnology and pharmaceutical industry and related fields.

Life @AlloVir

Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.

Board of Directors

Derek Adams, Ph.D

Chief Executive Officer, Stellular Bio

Derek Adams, Ph.D. has extensive experience in building manufacturing capabilities and navigating the regulatory Chemistry, Manufacturing and Controls (CMC) landscape from development through commercialization for advanced medicinal products including cell therapies.

Jeffrey Bornstein

Managing Partner at Generation Capital Partners and Founder and Principal of Whipstick Ventures LLC

Jeffrey Bornstein serves as a managing partner of Whipstick Ventures and Generation Capital, and was the Chief Financial Officer and Vice Chairman of General Electric until October 2017.

Diana M. Brainard, MD

Chief Executive Officer, AlloVir

Diana Brainard, MD, has more than 20 years of experience in academic medicine and the biopharmaceutical industry, has authored more than 200 publications, and brings a passion for advancing therapies for life-threatening diseases.

Malcolm Brenner, MD, PhD

Founding Director of Baylor College of Medicine’s Center for Cell and Gene Therapy

Malcolm Brenner, MD, PhD, is the founding director of the Center for Cell and Gene Therapy and the Fayez Sarofim Distinguished Service Professor at Baylor College of Medicine in the Departments of Medicine, Pediatrics, and Human and Molecular Genetics.

Executive Chairman of the Board

David Hallal is a proven 30-year veteran in the biopharmaceutical industry, having grown and operated several successful biotechnology companies.

Morana Jovan-Embiricos, PhD

Managing Partner, F2 Ventures

Morana Jovan-Embiricos, PhD, co-founded F2 Ventures, a biotech venture capital platform, in 2003 and has since served as its Managing Partner.

President and Chief Financial Officer

Vikas Sinha brings more than 25 years of experience in executive finance roles within the biopharmaceutical industry.

Shawn Tomasello

Shawn Tomasello brings more than 35 years of broad experience building and leading commercial organizations in the life sciences industry, with specific expertise in cell and gene therapy.

Juan F. Vera, MD

Associate Professor, Baylor College of Medicine

Juan Vera, MD, has more than 15 years of experience performing research in the field of adoptive T cell therapy and has made several contributions in the field.

Scientific Advisory Board

Michael Boeckh, MD, PhD

Head of Infectious Disease Sciences Program, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center ┃ Professor of Medicine, Fred Hutchinson Cancer Center and the University of Washington

Anil Chandraker, MD

Director of Renal Transplant Medicine, Brigham and Women’s Hospital ┃ Associate Professor of Medicine, Harvard Medical School

Stella Davies, MBBS, PhD, MRCP

Director, Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital

John F. DiPersio

Director, Center for Gene and Cellular Immunotherapy, WUSM. ┃ Professor of Medicine, Pathology & Immunology, Washington University School of Medicine (WUSM)

John W. Mellors, MD

Distinguished Professor of Medicine, Chief of Infectious Diseases, and Endowed Chair for Global Elimination of HIV and AIDS, University of Pittsburgh School of Medicine and UPMC Health System

Gérard Socié, MD, PhD

Head, Hematology-Transplantation, AP-HP Hospital St Louis, Paris ┃ Professor of Hematology, University of Paris

Life @ AlloVir

You want your life outside the lab to be as purposeful as your life inside it. We have the benefits to support you.

PTO Policies

Making sure that you have the freedom to time off when you need to is an important part of our culture. Life beyond the lab includes a flexible approach to PTO; you take it when you need it.

Life @AlloVir

Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.

401k Plans

We offer 401(k) matching, employer-paid life short and long-term disability, and life insurance.

Life @AlloVir

Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.

Healthcare

Our health plans include medical, vision, and dental covered at 90%, as well as Flexible Spending Accounts (FSA) and Dependent Care Accounts (DCA).

Life @AlloVir

Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.

Family Leave

Growing and taking care of your family is as important as the work you do. We offer a generous parental leave program that allows you to do just that.

Life @AlloVir

Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.

Cell phone and commuter reimbursement

Being connected and getting where you need to go is an important part of your work. We offer cell phone and commuter reimbursement programs that acknowledge the time you spend in and out of the office.

Life @AlloVir

Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.

AlloVir is the global leader in developing VST immunotherapies

We develop highly innovative, allogeneic, off-the-shelf, virus-specific T cell (VST) therapies designed to prevent and treat life-threatening viral diseases.

Our Pipeline

Our allogeneic, off-the-shelf VST therapy candidates target 11 different devastating viruses as treatment or prevention.

Our Platform

Our proprietary platform develops allogeneic, off-the-shelf VSTs designed to restore immunity in patients with T cell deficiencies.

Our People

We are united in purpose around a singular mission to prevent and defeat life-threatening viral diseases.

AlloVir does not control and is not responsible for the content on the website you are about to visit. AlloVir is providing this link as a convenience, and this link does not imply AlloVir’s endorsement of any material on the website you are about to visit. Do you wish to continue?

AlloVir does not control and is not responsible for the content on the website you are about to visit. AlloVir is providing this link as a convenience, and this link does not imply AlloVir’s endorsement of any material on the website you are about to visit. Do you wish to continue?